PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportspsychotic disorders
MeSH D011618 - psychotic disorders
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D019967:Schizophrenia spectrum and other psychotic disorders
$
Success rate
D011618: 
Psychotic disorders
D011605:Substance-induced psychoses
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaChlorpromazine Chlorpromazine  1982-01-01   
Clozapine Clozapine  1997-11-26   
Fluphenazine decanoate Fluphenazine Decanoate  1996-09-10   
Haloperidol Haloperidol  1987-08-25   
Haloperidol decanoate Haloperidol Decanoate  1999-05-11   
Loxapine Loxitane  1982-01-01   
Loxapine Loxitane C  1982-01-01   
Olanzapine Olanzapine  2011-10-24   
Olanzapine, Fluoxetine Olanzapine Fluoxetine  2012-06-19   
Olanzapine Olanzapine Teva  2007-12-12   
Pimozide Orap  1984-07-31   
Amitriptyline, Perphenazine Perphenazine Amitriptyline  1986-09-11   
Quetiapine Quetiapine  2012-03-27   
THIOTHIXENE Thiothixene  1987-06-22   
Trifluoperazine Trifluoperazine  1982-11-19   
Novast LaboratoriesQuetiapine Quetiapine  2017-11-29   
Taro PharmaceuticalFluphenazine Fluphenazine  2022-04-14   
Glenmark PharmaceuticalsChlorpromazine Chlorpromazine  2021-03-23   
Olanzapine Olazax  2009-12-11   
Olanzapine Olazax Disperzi  2009-12-10   
Fluphenazine Fluphenazine  2023-11-06   
MylanClozapine Clozapine  1999-05-27   
Fluphenazine decanoate Fluphenazine Decanoate  2001-08-17   
Haloperidol Haloperidol  1986-06-10   
Haloperidol decanoate Haloperidol Decanoate  2000-02-28   
Olanzapine Olanzapine  2014-05-12   
Olanzapine Olanzapine Mylan  2008-10-06   
Perphenazine Perphenazine  2017-04-14   
Amitriptyline, Perphenazine Perphenazine Amitriptyline  1988-11-10   
Quetiapine Quetiapine  2012-03-27   
Thioridazine Thioridazine  1983-03-15   
Trifluoperazine Trifluoperazine  1997-07-07   
NATCO PharmaOlanzapine Olanzapine  2012-04-23   
Johnson & JohnsonHaloperidol, Haloperidol decanoate Haldol  1982-01-01   
Paliperidone Invega  2007-06-24 $4,067 M Q2/24-Q1/25 
GSKTrifluoperazine Stelazine  1982-01-01   
Chlorpromazine Thorazine  1982-01-01   
RocheChlorprothixene Taractan  1982-01-01   
1
2
3
4
5
6
...
14
>
Clinical Trials
Historical Success Rate
Phase 1
73%
32/44
Phase 2
72%
64/89
Phase 3
66%
55/83
Approved: 27Overall Success rate: 35%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
4
5
6
...
10
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use